B

Biogen

Develops therapies for neurological disorders

Senior Director - Immunology Early Development Strategy & Innovation

Biology & BiotechConfirmed live in the last 24 hours
Full-timeCambridge, MA, USAHybrid

About the Job

Requirements

  • MD, MD/PhD, PhD, PharmD, or equivalent doctoral degree in a relevant biomedical discipline.
  • At least 15 years in pharmaceutical or biotechnology drug development, with progressive leadership responsibilities in research, pharmacology, clinical development, portfolio strategy, or external innovation.
  • Expertise in immunology and immune-mediated diseases, with experience spanning one or more areas such as rheumatology, dermatology, gastroenterology, allergy, inflammation, or related fields.
  • Demonstrated experience with multiple therapeutic modalities and driving through key development milestones.
  • Demonstrated success bridging discovery and translational science to clinical development, including leadership of research-to-development transitions and early development strategies through key value-inflection milestones.
  • Experience evaluating external opportunities, including business development, licensing, partnerships, venture investments, or strategic collaborations.
  • Strong understanding of the scientific, clinical, regulatory, and commercial factors that influence development and portfolio decisions.
  • Demonstrated ability to influence stakeholders up and down the organization and lead across a complex matrixed environment.
  • Exceptional strategic thinking, judgment, and problem-solving skills, with the ability to make high-quality recommendations and articulate trade-offs in the face of uncertainty.
  • Excellent communication and executive presence, with the ability to distill complex issues into clear, decision-ready recommendations.

Responsibilities

  • Act as a senior advisor and delegate of the Head of Immunology Early Development Innovation and Strategy, helping shape and execute key portfolio, organizational, and external priorities in Immunology.
  • Lead the strategy for critical research-to-development transitions, early development planning, and portfolio decisions across selected Immunology programs.
  • Serve as the delegated clinical development leader for select programs and portfolio initiatives to accelerate value creation.
  • Drive evaluation of external opportunities for the Immunology Development Unit, integrating scientific, clinical, strategic, and commercial perspectives into meaningful clinical development plans.
  • Develop evidence-based recommendations for governance and investment decisions, helping senior leaders navigate uncertainty and complexity.
  • Foster productive collaborations across Research, Development, Commercial, Corporate Strategy, Business Development, and external partners.
  • Influence and align cross-functional stakeholders to translate strategy into decisive action and execution.
  • Mentor colleagues and strengthen organizational capability through thought partnership, coaching, and leadership.
  • Ensure all activities are conducted in accordance with applicable regulatory, quality, ethical, and compliance standards.

Desired Qualifications

  • Recognized scientific or development leadership demonstrated through publications, presentations, patents, advisory roles, or equivalent accomplishments.
  • Experience leading teams through important regulatory milestones in early development, such as pre-IND or CTA meetings and clinical hold resolution.

About the Company

Biogen

Develops therapies for neurological disorders

Biogen is a global biotechnology company focused on neuroscience. It discovers, develops, and delivers therapies for neurological disorders, such as multiple sclerosis and other neurodegenerative diseases. Its product process starts with research and development to identify potential drugs, followed by clinical testing and regulatory approval, ultimately leading to commercialization and patient treatment. Biogen differentiates itself through a long history (founded in 1978), a deep specialization in neuroscience, and an integrated pipeline that moves ideas from discovery to approved medicines, aiming to create value for shareholders while helping communities. The company’s goal is to advance therapies for neurological diseases to improve patients’ lives and generate sustainable value for stakeholders.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
1978

Recently Posted Jobs

Explore more opportunities at Biogen

See more jobs